Yeah, I’m not adopting that position. But George does have a point that the FDA has provisionally approved drugs that did not meet endpoints. I can’t say what the odds are. He is defining “failed” differently than “didn’t meet endpoints.” And there may or may not be a practical difference in those two terms, in this case.